Skip to main content

CORRECTION article

Front. Immunol., 24 July 2019
Sec. Molecular Innate Immunity
Volume 10 - 2019 | https://doi.org/10.3389/fimmu.2019.01755
This article is part of the Research Topic The Role of Pentraxins: From Inflammation, Tissue Repair and Immunity to Biomarkers View all 21 articles

Corrigendum: PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases

This article is a correction to:

  1. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases

    1. Read original article
\nGiuseppe A. Ramirez,,Giuseppe A. Ramirez1,2,3Patrizia Rovere-Querini,Patrizia Rovere-Querini1,3Miriam Blasi,Miriam Blasi1,3Silvia SartorelliSilvia Sartorelli1Maria Chiara Di ChioMaria Chiara Di Chio1Mattia Baldini,Mattia Baldini1,3Rebecca De Lorenzo,Rebecca De Lorenzo1,3Enrica P. BozzoloEnrica P. Bozzolo2Roberto LeoneRoberto Leone4Alberto Mantovani,,Alberto Mantovani4,5,6Angelo A. Manfredi,, Angelo A. Manfredi1,2,3*Enrico Tombetti,,Enrico Tombetti1,2,3
  • 1Università Vita-Salute San Raffaele, Milan, Italy
  • 2Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
  • 3Division of Immunology, Transplantation and Infectious Immunity, IRCCS Ospedale San Raffaele, Milan, Italy
  • 4Humanitas Research Center - IRCCS, Rozzano, Italy
  • 5Humanitas University, Rozzano, Italy
  • 6The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

A Corrigendum on
PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases

by Ramirez, G. A., Rovere-Querini, P., Blasi, M., Sartorelli, S., Di Chio, M. C., Baldini, M., et al. (2019). Front. Immunol. 10:1135. doi: 10.3389/fimmu.2019.01135

In the original article, we neglected to include the funder “Cluster Alisei (MEDINTECH CTN01_00177_962865)” to Alberto Mantovani.

A correction has therefore been made to the Funding statement:

“This work was supported by grants from the MIUR (2015MGBEM2_002), and the Ministero della Salute (RF_2013_02358715) to AAM as well as the PR-Q and European Research Council (ERC – No 69415), Fondazione Cariplo (Contract no. 2015-0564) and Cluster Alisei (MEDINTECH CTN01_00177_962865) to AM.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: PTX3, autoimmunity, lupus, rheumatoid arthritis, Takayasu arteritis, giant cell arteritis, ANCA associated small vessel vasculitis, intravascular immunity

Citation: Ramirez GA, Rovere-Querini P, Blasi M, Sartorelli S, Di Chio MC, Baldini M, De Lorenzo R, Bozzolo EP, Leone R, Mantovani A, Manfredi AA and Tombetti E (2019) Corrigendum: PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases. Front. Immunol. 10:1755. doi: 10.3389/fimmu.2019.01755

Received: 11 July 2019; Accepted: 11 July 2019;
Published: 24 July 2019.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Ramirez, Rovere-Querini, Blasi, Sartorelli, Di Chio, Baldini, De Lorenzo, Bozzolo, Leone, Mantovani, Manfredi and Tombetti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Angelo A. Manfredi, manfredi.angelo@hsr.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.